1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 424 F.Supp.3d
  5. 424 F.Supp.3d 303 (2020)
 

BIOGEN INTERNATIONAL GMBH v. BANNER LIFE SCIENCES

C.A. No. 18-2054-LPS.

424 F.Supp.3d 303 (2020)

BIOGEN INTERNATIONAL GMBH, Plaintiff, v. BANNER LIFE SCIENCES LLC, Defendant.

United States District Court, D. Delaware.

UNSEALED ON January 9, 2020.

Editors Note
Applicable Law: 35 U.S.C. § 271
Cause: 35 U.S.C. § 271 Patent Infringement
Nature of Suit: 835 Patent - Abbreviated New Drug Application(ANDA)
Source: PACER

Attorney(s) appearing for the Case

Steven J. Balick, Andrew C. Mayo, ASHBY & GEDDES, Wilmington, DE, James B. Monroe, Paul W. Browning, Li Feng, Andrew E. Renison, Jeanette M. Roorda, FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LLP, Washington, DC, Attorneys for Plaintiff.

Karen E. Keller, David M. Fry, Nathan R. Hoeschen, SHAW KELLER LLP, Wilmington, DE, C. Kyle Musgrove, PARKER POE ADAMS & BERNSTEIN LLP, Charlotte, NC, Scott A. Cunning, II, John W. Bateman, Elizabeth M. Crompton, PARKER POE ADAMS & BERNSTEIN LLP, Washington, DC, Attorneys for Defendant.

MEMORANDUM OPINION

Plaintiff Biogen International GmbH ("Biogen") alleges that Defendant Banner Life Sciences LLC ("Banner") infringes Biogen's U.S. Patent No. 7,619,001 ("the '001 Patent"), which is subject to a patent term extension. (D.I. 1) Banner has moved under Rule 12(c) for judgment...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases